Andere talen Nexstim Plc

Aandelen

Beurs gesloten - Nasdaq Helsinki Andere beurzen 17:10:52 24-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,79 ^EUR	0,00%		-3,79%	-5,10%

08/05	Nexstim Plc ontvangt een order voor een NBS Systeem 5 van een ziekenhuis in Finland	CI
06/05	Nexstim Plc ontvangt goedkeuring van Health Canada voor de marketing en commerciële distributie van haar NBS 6-systeem voor de behandeling van depressieve stoornissen	CI

Finnish Hospital Orders Nexstim NBS System 5	08/05
Nexstim Plc Receives an Order for an NBS System 5 from a Hospital in Finland	08/05
Health Canada Approves Nexstim NBS 6 System for Treatment of MDD	06/05
Nexstim plc Receives Approval from Health Canada for the Marketing and Commercial Distribution of Its NBS 6 System for the Treatment of Major Depressive Disorder	06/05
Nexstim, Inc. and Inomed Inc. Enter into Strategic Alliance Agreement for US Market	03/05
Neurosurgery Customer from Germany Orders Nexstim NBS System 5	26/04
Nexstim plc Receives Order for A New NBS System 5 from an Existing Customer Hospital in Germany	26/04
Nexstim Plc Business Update Q1 2024	26/04
Nexstim Plc: Managers’ Transactions, Hildén	25/04
Nexstim Plc: Managers’ Transactions, Forss	25/04
Nexstim Plc: Managers’ Transactions, Weckroth	25/04
Nexstim Plc: Managers’ Transactions, Niemistö	25/04
Nexstim Wins Order for Navigated Brain Stimulation System in US	22/04
Nexstim Receives NBS 6 System Order from Clinic in Florida, US	22/04
Nexstim Receives NBS 6 System Order from Clinic in Florida, US	22/04
Nexstim Plc Resolved on a New Stock Option Plan 2024H	12/04
Nexstim Plc: Resolutions of the Annual General Meeting of Shareholders	28/03
Nexstim Plc: Invitation to the Annual General Meeting	07/03
Nexstim : Financial Document	06/03
Nexstim Plc Publishes 2023 Annual Report	06/03

Geen resultaten voor deze zoekopdracht